CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
46-60 of 1187
When Itching Hurts: Quality of Life Disruption in CKD-aP
MinuteCE®When Itching Hurts: Quality of Life Disruption in CKD-aP
Nancy Helou, PhD
Steven Fishbane, MD
Conference Coverage at ICCBH 2026: From Achondroplasia Presentation to Practice
CME/CEConference Coverage at ICCBH 2026: From Achondroplasia Presentation to Practice
Ravi Savarirayan, MBBS, MD
Julie Hoover-Fong, MD, PhD, FACMGG
Menin Inhibitors in AML: Six Clinical Showdowns That Shape Real-World Practice
CME/CEMenin Inhibitors in AML: Six Clinical Showdowns That Shape Real-World Practice
Amer Zeidan, MBBS
Ghayas Issa, MD
Kathleen N. Moore, MD
Ritu Salani, MD
Case Consult: Personalizing First-Line Maintenance Therapy in Advanced Ovarian Cancer
MinuteCE®Case Consult: Personalizing First-Line Maintenance Therapy in Advanced Ovarian Cancer
Kathleen N. Moore, MD
Ritu Salani, MD
Case Consult: Targeting CDH6 in Platinum-Resistant Ovarian Cancer
MinuteCE®Case Consult: Targeting CDH6 in Platinum-Resistant Ovarian Cancer
Kathleen N. Moore, MD
Ritu Salani, MD
- advertisement
Case Consult: Treatment Strategies for FRα-Positive Platinum-Resistant Ovarian Cancer
MinuteCE®Case Consult: Treatment Strategies for FRα-Positive Platinum-Resistant Ovarian Cancer
Kathleen N. Moore, MD
Ritu Salani, MD
Case Consult: Treatment Strategies for HER2-Positive Platinum-Resistant Ovarian Cancer
MinuteCE®Case Consult: Treatment Strategies for HER2-Positive Platinum-Resistant Ovarian Cancer
Kathleen N. Moore, MD
Ritu Salani, MD
Case Consult: PD-L1–Guided Treatment Decisions in Platinum-Resistant Ovarian Cancer
MinuteCE®Case Consult: PD-L1–Guided Treatment Decisions in Platinum-Resistant Ovarian Cancer
Kathleen N. Moore, MD
Ritu Salani, MD
Raising the Bar for Hodgkin Lymphoma: Optimizing Immunotherapy in Community Practice
CME/CERaising the Bar for Hodgkin Lymphoma: Optimizing Immunotherapy in Community Practice
Alex F. Herrera, MD
- CME/CE In-Person & Virtual Event
Illuminating Patient Selection for PBM in AMD: A Case-Based Discussion
October 10, 2026
New Orleans, Louisiana - advertisement
Novel Approaches in Early and Intermediate AMD: A Mechanistic Deep Dive
CME/CENovel Approaches in Early and Intermediate AMD: A Mechanistic Deep Dive
Diana V. Do, MD
Janis T. Eells, Ph.D.
David Boyer, MD
Eleonora Lad, MD, PhD
Marion R. Munk, MD, PhD
Michael A. Levine, MD, ML, MACE
Aliya Khan, MD, FRCPC, FACP, FACE, FASBMR
